About Us
Based near Oxford, UK, Glide Pharma is developing a pipeline of both Glide-branded generic products and co-developed originator products based on its proprietary Glide technology that allows the injection of drugs, vaccines and other active pharmaceutical ingredients in a solid form. Glide is an innovative new needle-free injection system that offers significant benefits and opportunities to drug developers, healthcare providers, patients and their carers.
Glide Pharma has made great progress since its foundation in 2001, when it took its original name of Caretek Medical Ltd. Glide Pharma has an experienced Management Team and a strong Board of Directors who are focused on making Glide Pharma a leading manufacturer of pharmaceutical products and the partner of choice for pharmaceutical and biotechnology companies looking for the best drug delivery options for their patients.
Glide Pharma’s first product will be a needle-free injectable formulation of sumatriptan to treat migraine. The Glide technology will provide migraine suffers a simple, clean and easy to use injectable sumatriptan product that will provide rapid and reliable relief of their symptoms, which is often not the case with tablet or nasal formulations.
Glide Pharma is also co-developing novel products with pharmaceutical partners. Glide Pharma formulates the partner’s drug into a solid dosage form suitable for injection with the needle-free Glide technology. The ability to inject drugs as solids offers pharmaceutical companies a valuable new option for drug delivery, providing a stable, controllable and clean mechanism to deliver drugs and vaccines directly into the body’s tissues.
